MA28943B1 - Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations - Google Patents

Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations

Info

Publication number: MA28943B1
Authority: MA; Morocco
Prior art keywords: methods; receptor binding; mimetic; compositions; melanocortin receptor
Prior art date: 2004-10-25

Application number

MA29843A

Other languages

English (en)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Centocor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2007-04-23

Publication date

2007-10-01

2007-04-23 Application filed by Centocor Inc filed Critical Centocor Inc

2007-10-01 Publication of MA28943B1 publication Critical patent/MA28943B1/fr

Links

102000004378 Melanocortin Receptors Human genes 0.000 title abstract 2
108090000950 Melanocortin Receptors Proteins 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
102000040430 polynucleotide Human genes 0.000 abstract 2
108091033319 polynucleotide Proteins 0.000 abstract 2
239000002157 polynucleotide Substances 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Toxicology (AREA)
Biophysics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Biotechnology (AREA)
Emergency Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA29843A 2004-10-25 2007-04-23 Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations MA28943B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25

Publications (1)

Publication Number	Publication Date
MA28943B1 true MA28943B1 (fr)	2007-10-01

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29843A MA28943B1 (fr)	2004-10-25	2007-04-23	Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations

Country Status (28)

Country	Link
US (1)	US20060105951A1 (fr)
EP (1)	EP1812046B1 (fr)
JP (1)	JP2008517605A (fr)
KR (1)	KR101255140B1 (fr)
CN (1)	CN101437540B (fr)
AT (1)	ATE501731T1 (fr)
AU (1)	AU2005299440B2 (fr)
BR (1)	BRPI0518411A2 (fr)
CA (1)	CA2585287A1 (fr)
CY (1)	CY1111486T1 (fr)
DE (1)	DE602005026970D1 (fr)
DK (1)	DK1812046T3 (fr)
EA (1)	EA200700944A1 (fr)
EC (1)	ECSP077416A (fr)
ES (1)	ES2363023T3 (fr)
HR (1)	HRP20110405T1 (fr)
IL (1)	IL182683A0 (fr)
MA (1)	MA28943B1 (fr)
ME (1)	ME01234B (fr)
MX (1)	MX2007004974A (fr)
NO (1)	NO20072499L (fr)
PL (1)	PL1812046T3 (fr)
PT (1)	PT1812046E (fr)
RS (1)	RS51789B (fr)
SI (1)	SI1812046T1 (fr)
TN (1)	TNSN07157A1 (fr)
WO (1)	WO2006047535A2 (fr)
ZA (1)	ZA200704260B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en)	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
TW201002340A (en) *	2008-06-09	2010-01-16	Palatin Technologies Inc	Melanocortin receptor-specific peptides for treatment of obesity
WO2009152079A1 (fr)	2008-06-09	2009-12-17	Palatin Technologies, Inc.	Peptides spécifiques du récepteur de mélanocortine pour le traitement d'un dysfonctionnement sexuel
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
EP2440572B1 (fr)	2009-06-08	2017-04-05	Palatin Technologies, Inc.	Peptides spécifiques des récepteurs aux mélanocortines à pont lactame
EA020959B1 (ru)	2009-06-08	2015-03-31	Палатин Текнолоджиз, Инк.	Пептиды, специфичные к меланокортиновым рецепторам
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
EA021897B1 (ru)	2009-11-23	2015-09-30	Палатин Текнолоджиз, Инк.	Циклические пептиды, специфичные к рецептору меланокортина-1
BR112012011780A2 (pt)	2009-11-23	2019-09-24	Palatin Technologies, Inc	peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
CN113272330B (zh) *	2019-03-02	2024-07-26	南通壹宸生物医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2353776A1 (fr) *	1998-12-09	2000-06-15	Eleanor Roosevelt Institute	Composition et procedes de regulation du poids corporel et des pathologies associees
WO2002006316A2 (fr) *	2000-07-14	2002-01-24	Zycos, Inc.	Composes en rapport avec $g(a)-msh et methodes d'utilisation
BR0312276A (pt)	2002-06-28	2005-04-26	Centocor Inc	Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
CA2490409A1 (fr) *	2002-06-28	2004-01-08	Centocor, Inc.	Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
EA011583B1 (ru) *	2004-03-31	2009-04-28	Сентокор, Инк.	Миметические антитела glp-1 человека, композиции, способы и применения

2005
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 EP EP05819741A patent/EP1812046B1/fr not_active Expired - Lifetime
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de not_active Expired - Lifetime
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 RS RS20110230A patent/RS51789B/sr unknown
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/fr unknown
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 CA CA002585287A patent/CA2585287A1/fr not_active Abandoned
- 2005-10-25 HR HR20110405T patent/HRP20110405T1/hr unknown
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active Expired - Fee Related
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es not_active Expired - Lifetime
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/fr not_active Ceased
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown

Also Published As

Publication number	Publication date
WO2006047535A2 (fr)	2006-05-04
IL182683A0 (en)	2007-09-20
CN101437540B (zh)	2012-12-19
KR101255140B1 (ko)	2013-04-22
ES2363023T3 (es)	2011-07-19
JP2008517605A (ja)	2008-05-29
DE602005026970D1 (de)	2011-04-28
HK1106445A1 (en)	2008-03-14
EP1812046A4 (fr)	2009-11-11
PT1812046E (pt)	2011-06-28
EP1812046A2 (fr)	2007-08-01
ZA200704260B (en)	2009-03-25
CN101437540A (zh)	2009-05-20
NO20072499L (no)	2007-07-16
MX2007004974A (es)	2007-10-17
KR20070085416A (ko)	2007-08-27
DK1812046T3 (da)	2011-06-06
AU2005299440A1 (en)	2006-05-04
BRPI0518411A2 (pt)	2008-11-18
EA200700944A1 (ru)	2008-04-28
ME01234B (fr)	2013-06-20
EP1812046B1 (fr)	2011-03-16
US20060105951A1 (en)	2006-05-18
PL1812046T3 (pl)	2011-08-31
TNSN07157A1 (en)	2008-11-21
ATE501731T1 (de)	2011-04-15
AU2005299440B2 (en)	2011-12-15
HRP20110405T1 (hr)	2011-06-30
SI1812046T1 (sl)	2011-06-30
WO2006047535A3 (fr)	2008-09-04
CY1111486T1 (el)	2015-08-05
CA2585287A1 (fr)	2006-05-04
RS51789B (sr)	2011-12-31
ECSP077416A (es)	2007-05-30

Publication	Publication Date	Title
NO20072499L (no)	2007-07-16	Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser
NO345048B1 (no)	2020-09-07	Antigen-bindende protein som binder til humant IGF-1R, polynukleotid som koder for dette, samt plasmid og celle, og farmasøytisk sammensetning.
EP1907001A4 (fr)	2010-01-13	Molecules de liaison ilt3 et leurs utilisations
DK1864132T3 (da)	2012-07-16	Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
NO20024489D0 (no)	2002-09-19	Multifunksjonelle polypeptider som omfatter et bindingssete til et epitop i NKG2D reseptor-komplekset
WO2007104062A3 (fr)	2008-11-27	Compositions et procédés concernant le profilage d'une pluralité de lignées cellulaires en fonction de leur liaison à des peptides
EA201490263A1 (ru)	2014-10-30	Связующие и изготовленные с их помощью материалы
ATE539170T1 (de)	2012-01-15	Abschätzung und verringerung des risikos von graft-versus-host-reaktion
EP1553975A4 (fr)	2006-09-27	Variants fc optimises et methodes destinees a leur generation
BRPI0613770A2 (pt)	2009-05-19	anticorpos anti-cd26 e métodos de uso destes
NO20062087L (no)	2006-07-07	Bispesifikt antistoff som substituerer for funksjonelle proteiner
NO20066050L (no)	2007-02-05	Substituerte indazoler, sammensetninger inneholdende disse samt fremstilling og anvendelse derav
ATE493081T1 (de)	2011-01-15	Faserverstärktes verbundmaterial
DK1328297T3 (da)	2010-02-01	Funktionen af en haptoglobin-hæmoglobin receptor og anvendelser heraf
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
CR9637A (es)	2008-03-06	Proteinas de enlace il-6
NO20091181L (no)	2009-05-18	Anti-C5AR-antistoffer med forbedrede egenskaper
MX2009006879A (es)	2009-07-03	Anticuerpos contra el cd200r.
WO2007030426A3 (fr)	2007-07-26	Procedes d'utilisation et d'analyse de donnees de sequences biologiques
WO2005028497A3 (fr)	2006-02-23	Peptides se liant a des recepteurs derives de proteines sars s
NO20085224L (no)	2009-02-26	Vurdering av funksjonell status
WO2007008539A3 (fr)	2007-05-10	Composes chimiques
ATE471169T1 (de)	2010-07-15	Engineering mit homing-faktoren
EP2488200A4 (fr)	2013-06-12	Antagonistes d'april et méthodes d'utilisation
MX2007010332A (es)	2008-02-21	Metodos y composiciones para promover adhesion o migracion de celula endotelial.